What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Enzyme
David A. Lomas mainly investigates COPD, Internal medicine, Biochemistry, Protein structure and Familial encephalopathy with neuroserpin inclusion bodies.
His biological study spans a wide range of topics, including Exacerbation, Immunology, Biomarker, Prospective cohort study and Surrogate endpoint.
His research integrates issues of Physical therapy and Pathology in his study of Internal medicine.
The various areas that David A. Lomas examines in his Biochemistry study include Molecular biology, Toxicity and Alpha 1-antitrypsin deficiency.
His Protein structure research includes elements of Drug design, Crystallography, Protein folding, Stereochemistry and Reactive center.
His Familial encephalopathy with neuroserpin inclusion bodies research is multidisciplinary, incorporating elements of Biophysics and Neuroserpin.
His most cited work include:
- Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease (1876 citations)
- The serpins are an expanding superfamily of structurally similar but functionally diverse proteins - Evolution, mechanism of inhibition, novel functions, and a revised nomenclature (1046 citations)
- The mechanism of Z alpha 1-antitrypsin accumulation in the liver. (881 citations)
What are the main themes of his work throughout his whole career to date?
David A. Lomas spends much of his time researching COPD, Internal medicine, Immunology, Serpin and Biochemistry.
His work deals with themes such as Genome-wide association study, Single-nucleotide polymorphism, Pulmonary disease, Exacerbation and Physical therapy, which intersect with COPD.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Pathology.
His research in Serpin intersects with topics in Serine, Neuroserpin, Familial encephalopathy with neuroserpin inclusion bodies, Point mutation and Protein structure.
David A. Lomas works mostly in the field of Neuroserpin, limiting it down to concerns involving Endoplasmic reticulum and, occasionally, Mutant and Intracellular.
As a part of the same scientific family, David A. Lomas mostly works in the field of Alpha 1-antitrypsin deficiency, focusing on Molecular biology and, on occasion, Secretion.
He most often published in these fields:
- COPD (37.94%)
- Internal medicine (30.04%)
- Immunology (19.76%)
What were the highlights of his more recent work (between 2016-2021)?
- COPD (37.94%)
- Internal medicine (30.04%)
- Fluticasone propionate (7.31%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include COPD, Internal medicine, Fluticasone propionate, Vilanterol and Exacerbation.
His studies deal with areas such as Genome-wide association study, Immunology, Lung, Genetic association and Treatment response as well as COPD.
His Immunology research includes themes of Phenotype and Pulmonary fibrosis.
His Internal medicine study frequently links to other fields, such as Gastroenterology.
His studies in Fluticasone propionate integrate themes in fields like Clinical trial and Hazard ratio.
He has researched Exacerbation in several fields, including Dual therapy, Disease and Lung function.
Between 2016 and 2021, his most popular works were:
- Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD (398 citations)
- Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis (170 citations)
- FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease (163 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Enzyme
His scientific interests lie mostly in COPD, Internal medicine, Fluticasone propionate, Vilanterol and Exacerbation.
The study incorporates disciplines such as Genome-wide association study, Inflammation, Immunology, Genetic association and Physical therapy in addition to COPD.
His Immunology study combines topics from a wide range of disciplines, such as Population study, Lung, Allele, Haplotype and Risk factor.
David A. Lomas works mostly in the field of Genetic association, limiting it down to topics relating to Genetic epidemiology and, in certain cases, Cohort and Chromosome 19, as a part of the same area of interest.
The Internal medicine study combines topics in areas such as Gastroenterology and Single-nucleotide polymorphism.
His Fluticasone propionate research incorporates elements of Inhaler and Budesonide, Formoterol.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
